340B Drug Pricing Program: How It Works and Who Is Eligible

Learn how the 340B drug pricing program works, who's eligible, and what compliance requirements covered entities need to follow.

340B Drug Pricing Program: How It Works and Who Is Eligible
340B Drug Pricing Program

The 340B drug pricing program helps certain healthcare organizations buy outpatient prescription drugs at reduced prices. The program was created to help eligible providers stretch limited resources and support care for underserved and vulnerable patients.

For healthcare organizations, understanding 340B eligibility, program requirements, and compliance is important. The rules can be detailed, and covered entities need strong processes to make sure their purchases and use of 340B drugs follow program requirements.

What Is the 340B Drug Pricing Program?

The 340B drug pricing program is a federal program that allows eligible healthcare organizations to purchase certain outpatient drugs at discounted prices from participating manufacturers.

The program is administered by the Health Resources and Services Administration (HRSA) through its Office of Pharmacy Affairs (OPA).

The basic idea is simple. Eligible organizations can reduce the amount they spend on covered outpatient drugs and use their available resources to support their healthcare services.

However, 340B is not simply a discount program. Covered entities must meet specific requirements and maintain accurate records to remain compliant.

How Does the 340B Program Work?

The 340B program connects eligible healthcare organizations with participating pharmaceutical manufacturers.

A covered entity first needs to qualify for the program and be registered with the appropriate federal program. Once eligible, the organization can purchase covered outpatient drugs at the applicable 340B price.

The process generally involves several important steps:

  1. The organization qualifies as a covered entity.

  2. The organization completes the required registration process.

  3. The entity purchases eligible outpatient drugs at 340B prices.

  4. The drugs are used according to program rules.

  5. The organization maintains records and controls to support compliance.

  6. The entity remains prepared for audits and other program oversight.

Pharmacies may also be involved through arrangements with covered entities. These arrangements need to follow applicable 340B rules and the covered entity remains responsible for meeting program requirements.

Who Is Eligible for the 340B Program?

340B eligibility is limited to organizations that fall within categories established by federal law.

Examples of 340B covered entities include certain:

  • Federally Qualified Health Centers

  • Ryan White HIV/AIDS Program grantees

  • Children’s hospitals

  • Disproportionate Share Hospitals

  • Critical Access Hospitals

  • Rural Referral Centers

  • Sole Community Hospitals

  • Certain specialized healthcare organizations

Eligibility can depend on the organization's specific category and other requirements. Being a healthcare provider alone does not automatically make an organization eligible for 340B.

Organizations should verify their specific eligibility requirements before entering the program.

What Are the Main 340B Program Requirements?

340B program requirements cover several areas, including purchasing, drug use, records, and oversight.

One of the most important requirements is preventing duplicate discounts. A manufacturer should not provide a 340B discount on a drug while the same drug is also subject to a Medicaid rebate in a way that creates an impermissible duplicate discount.

Another major requirement is preventing diversion. In general, 340B drugs must be provided to eligible patients of the covered entity under applicable program rules. They cannot simply be transferred to people who do not meet the program's patient requirements.

Covered entities also need appropriate internal controls and records to show that their 340B activity follows program rules.

Why Is 340B Compliance Important?

340B compliance helps protect an organization's eligibility and reduces the risk of problems during program oversight or an audit.

Weak controls can create issues such as incorrect purchases, diversion, duplicate discounts, inaccurate records, or other compliance concerns.

A strong compliance process should cover areas such as:

  • Eligibility verification

  • Drug purchasing

  • Inventory controls

  • Patient eligibility

  • Medicaid billing decisions

  • Contract pharmacy arrangements

  • Documentation

  • Internal monitoring

  • Audit preparation

The goal is not only to find problems after they happen. Good 340B compliance processes are designed to identify and prevent problems early.

What Are the Benefits of 340B Drug Pricing?

The main benefit of 340B drug pricing is that eligible organizations can reduce the cost of certain outpatient medications.

Those savings can help covered entities support their healthcare missions and manage limited resources.

The exact impact can vary between organizations. It depends on factors such as the entity's eligibility category, drug mix, patient population, purchasing activity, and operational model.

The program can therefore be valuable, but its benefits depend on proper administration and compliance.

Common 340B Compliance Challenges

Managing a 340B program can become complicated as an organization grows.

One common challenge is keeping information accurate across different systems. A covered entity may have data coming from its EHR, pharmacy system, purchasing platform, billing system, and other sources.

Another challenge is maintaining consistent processes across multiple locations or contract pharmacies.

Organizations may also struggle with:

  • Identifying eligible patients

  • Monitoring drug purchases

  • Managing inventory

  • Preventing duplicate discounts

  • Tracking contract pharmacy activity

  • Maintaining documentation

  • Preparing for audits

  • Keeping policies and procedures up to date

These challenges make regular monitoring important.

How Can Covered Entities Improve 340B Compliance?

A practical approach is to treat compliance as an ongoing process rather than a one-time review.

Start by clearly documenting who is responsible for each part of the 340B program. Then review the systems and controls used to manage purchasing, dispensing, billing, and reporting.

Regular reviews can help identify unusual transactions or gaps before they become larger problems.

Organizations can also use data validation to compare information from different systems. For example, purchasing data can be reviewed against dispensing and patient records to identify inconsistencies.

A structured review of the program can also help organizations identify areas that need attention. Healthcare organizations looking for additional information about managing and reviewing their 340B operations can explore resources from NorthArc Health.

Common Questions About the 340B Program

What is 340B eligibility?

340B eligibility means an organization meets the requirements for one of the covered entity categories established under federal law. The organization must also complete the required registration and follow applicable program rules.

Who are 340B covered entities?

340B covered entities include certain hospitals, federally qualified health centers, Ryan White HIV/AIDS Program organizations, and other healthcare organizations that meet specific statutory requirements.

Is every healthcare provider eligible for 340B?

No. A healthcare organization must fall within an eligible category and meet the applicable requirements. Simply providing healthcare services does not automatically qualify an organization for the program.

What is 340B compliance?

340B compliance means following the rules that govern the program, including requirements related to eligible patients, drug purchasing, diversion, duplicate discounts, records, and oversight.

Why are 340B records important?

Accurate records help an organization demonstrate that its purchases and use of 340B drugs follow program requirements. They also support internal monitoring and audit readiness.

Final Thoughts

The 340B drug pricing program can provide important savings for eligible healthcare organizations. But those savings come with responsibilities.

Understanding 340B eligibility is only the starting point. Covered entities also need reliable processes for purchasing, patient eligibility, inventory, billing, documentation, and ongoing compliance.

A well-managed 340B program combines accurate data, clear responsibilities, regular monitoring, and strong internal controls. This helps organizations protect their program participation while making better use of the resources available to support patient care.